Published in Healthcare Mergers, Acquisitions and Ventures Week, February 24th, 2007
This trend article about Amgen, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A report, "A novel method for detecting neutralizing antibodies against therapeutic proteins by measuring gene expression," is newly published data in Journal of Immunological Methods. According to a study from the United States, "The presence of neutralizing antibodies against protein therapeutics is a concern in the biomedical field. Such antibodies not only reduce the efficacy of protein therapeutics, but also impose potential dangers to the patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.